APO Research
Talk to an analyst

APO RESEARCH · REPORT

Critical Limb Ischemia Treatment

Critical limb ischemia (CLI) is a severe blockage in the arteries of the lower extremities, which markedly reduces blood-flow. It is a serious form of peripheral arterial disease, or PAD. PAD caused by atherosclerosis, the hardening and narrowing of the arteries over time due to the buildup of fatty deposits called plaque.Currently, the standard of care for patients battling CLI is balloon angioplasty, which relies on a small balloon delivered via a catheter to the blockage to compress it against the arterial wall, opening the vessel and restoring blood flow.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Critical limb ischemia (CLI) is a severe blockage in the arteries of the lower extremities, which markedly reduces blood-flow. It is a serious form of peripheral arterial disease, or PAD. PAD caused by atherosclerosis, the hardening and narrowing of the arteries over time due to the buildup of fatty deposits called plaque.Currently, the standard of care for patients battling CLI is balloon angioplasty, which relies on a small balloon delivered via a catheter to the blockage to compress it against the arterial wall, opening the vessel and restoring blood flow.

Selected research

Market Structure

Global Critical Limb Ischemia Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

29 December 2025196 pages

Choose your research edition.

Industry ResearchCritical Limb Ischemia Treatment Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Critical Limb Ischemia Treatment Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Critical Limb Ischemia Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Critical Limb Ischemia Treatment Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Critical Limb Ischemia Treatment Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

Critical limb ischemia (CLI) is a severe blockage in the arteries of the lower extremities, which markedly reduces blood-flow. It is a serious form of peripheral arterial disease, or PAD. PAD caused by atherosclerosis, the hardening and narrowing of the arteries over time due to the buildup of fatty deposits called plaque.Currently, the standard of care for patients battling CLI is balloon angioplasty, which relies on a small balloon delivered via a catheter to the blockage to compress it against the arterial wall, opening the vessel and restoring blood flow.

Global critical limb ischemia treatment includes Medtronic, Boston Scientific, Abbott, COOK and Cardiovascular Systems, etc. Global top 3 companies hold a share over 59%. North America is the largest market, with a share about 39%, followed by Europe and Asia-Pacific with the share about 31% and 22%.

Report Includes

Read the full market overview

This report provides an overview of the global Critical Limb Ischemia Treatment market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Critical Limb Ischemia Treatment and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Critical Limb Ischemia Treatment revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Critical Limb Ischemia Treatment market size, projected growth trends, production technologies, key applications, and end-use industries.

Critical Limb Ischemia Treatment Segment by Company

Medtronic

Boston Scientific

Abbott

COOK

Cardiovascular Systems

Terumo

B. Braun

Biotronik

MicroPort Medical

Lepu Medical

Micro Medical Solutions

Critical Limb Ischemia Treatment Segment by Type

Embolic Protection Devices

Peripheral Dilatation Systems

Drugs Treatment

Other

Critical Limb Ischemia Treatment Segment by Application

ASCs

Hospitals

Catheterization Laboratory

Critical Limb Ischemia Treatment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Critical Limb Ischemia Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Critical Limb Ischemia Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Critical Limb Ischemia Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Critical Limb Ischemia Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Critical Limb Ischemia Treatment industry.

Chapter 3: Detailed analysis of Critical Limb Ischemia Treatment companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Critical Limb Ischemia Treatmentrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Critical Limb Ischemia Treatment Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Embolic Protection Devices Table 3. Key Players of Peripheral Dilatation Systems Table 4. Key Players of Drugs Treatment Table 3. Key Players of Other Table 4. Global Critical Limb Ischemia Treatment Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of ASCs Table 6. Key Players of Hospitals Table 7. Key Players of Catheterization Laboratory Table 8. Global Critical Limb Ischemia Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Critical Limb Ischemia Treatment Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Critical Limb Ischemia Treatment Market Share by Region (2021-2026) Table 11. Global Critical Limb Ischemia Treatment Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Critical Limb Ischemia Treatment Market Share by Region (2027-2032) Table 13. Critical Limb Ischemia Treatment Industry Trends Table 14. Critical Limb Ischemia Treatment Industry Drivers Table 15. Critical Limb Ischemia Treatment Industry Opportunities and Challenges Table 16. Critical Limb Ischemia Treatment Industry Restraints Table 17. Global Critical Limb Ischemia Treatment Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Critical Limb Ischemia Treatment Revenue Market Share by Company (2021-2026) Table 19. Global Critical Limb Ischemia Treatment Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Critical Limb Ischemia Treatment Key Company Head Office and Area Served Table 21. Global Critical Limb Ischemia Treatment Company, Product Type & Application Table 22. Global Critical Limb Ischemia Treatment Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Critical Limb Ischemia Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Critical Limb Ischemia Treatment Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Critical Limb Ischemia Treatment Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Critical Limb Ischemia Treatment Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Critical Limb Ischemia Treatment Revenue Market Share by Type (2021-2026) Table 29. Global Critical Limb Ischemia Treatment Revenue Market Share by Type (2027-2032) Table 30. Global Critical Limb Ischemia Treatment Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Critical Limb Ischemia Treatment Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Critical Limb Ischemia Treatment Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Critical Limb Ischemia Treatment Revenue Market Share by Application (2021-2026) Table 34. Global Critical Limb Ischemia Treatment Revenue Market Share by Application (2027-2032) Table 35. Medtronic Company Information Table 36. Medtronic Business Overview Table 37. Medtronic Critical Limb Ischemia Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Medtronic Critical Limb Ischemia Treatment Product Portfolio Table 39. Medtronic Recent Development Table 40. Boston Scientific Company Information Table 41. Boston Scientific Business Overview Table 42. Boston Scientific Critical Limb Ischemia Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Boston Scientific Critical Limb Ischemia Treatment Product Portfolio Table 44. Boston Scientific Recent Development Table 45. Abbott Company Information Table 46. Abbott Business Overview Table 47. Abbott Critical Limb Ischemia Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Abbott Critical Limb Ischemia Treatment Product Portfolio Table 49. Abbott Recent Development Table 50. COOK Company Information Table 51. COOK Business Overview Table 52. COOK Critical Limb Ischemia Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. COOK Critical Limb Ischemia Treatment Product Portfolio Table 54. COOK Recent Development Table 55. Cardiovascular Systems Company Information Table 56. Cardiovascular Systems Business Overview Table 57. Cardiovascular Systems Critical Limb Ischemia Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Cardiovascular Systems Critical Limb Ischemia Treatment Product Portfolio Table 59. Cardiovascular Systems Recent Development Table 60. Terumo Company Information Table 61. Terumo Business Overview Table 62. Terumo Critical Limb Ischemia Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Terumo Critical Limb Ischemia Treatment Product Portfolio Table 64. Terumo Recent Development Table 65. B. Braun Company Information Table 66. B. Braun Business Overview Table 67. B. Braun Critical Limb Ischemia Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. B. Braun Critical Limb Ischemia Treatment Product Portfolio Table 69. B. Braun Recent Development Table 70. Biotronik Company Information Table 71. Biotronik Business Overview Table 72. Biotronik Critical Limb Ischemia Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Biotronik Critical Limb Ischemia Treatment Product Portfolio Table 74. Biotronik Recent Development Table 75. MicroPort Medical Company Information Table 76. MicroPort Medical Business Overview Table 77. MicroPort Medical Critical Limb Ischemia Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. MicroPort Medical Critical Limb Ischemia Treatment Product Portfolio Table 79. MicroPort Medical Recent Development Table 80. Lepu Medical Company Information Table 81. Lepu Medical Business Overview Table 82. Lepu Medical Critical Limb Ischemia Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Lepu Medical Critical Limb Ischemia Treatment Product Portfolio Table 84. Lepu Medical Recent Development Table 85. Micro Medical Solutions Company Information Table 86. Micro Medical Solutions Business Overview Table 87. Micro Medical Solutions Critical Limb Ischemia Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. Micro Medical Solutions Critical Limb Ischemia Treatment Product Portfolio Table 89. Micro Medical Solutions Recent Development Table 90. North America Critical Limb Ischemia Treatment Market Size by Type (2021-2026) & (US$ Million) Table 91. North America Critical Limb Ischemia Treatment Market Size by Type (2027-2032) & (US$ Million) Table 92. North America Critical Limb Ischemia Treatment Market Size by Application (2021-2026) & (US$ Million) Table 93. North America Critical Limb Ischemia Treatment Market Size by Application (2027-2032) & (US$ Million) Table 94. North America Critical Limb Ischemia Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 95. North America Critical Limb Ischemia Treatment Market Size by Country (2021-2026) Table 96. North America Critical Limb Ischemia Treatment Market Size by Country (2027-2032) Table 97. Europe Critical Limb Ischemia Treatment Market Size by Type (2021-2026) & (US$ Million) Table 98. Europe Critical Limb Ischemia Treatment Market Size by Type (2027-2032) & (US$ Million) Table 99. Europe Critical Limb Ischemia Treatment Market Size by Application (2021-2026) & (US$ Million) Table 100. Europe Critical Limb Ischemia Treatment Market Size by Application (2027-2032) & (US$ Million) Table 101. Europe Critical Limb Ischemia Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 102. Europe Critical Limb Ischemia Treatment Market Size by Country (2021-2026) Table 103. Europe Critical Limb Ischemia Treatment Market Size by Country (2027-2032) Table 104. China Critical Limb Ischemia Treatment Market Size by Type (2021-2026) & (US$ Million) Table 105. China Critical Limb Ischemia Treatment Market Size by Type (2027-2032) & (US$ Million) Table 106. China Critical Limb Ischemia Treatment Market Size by Application (2021-2026) & (US$ Million) Table 107. China Critical Limb Ischemia Treatment Market Size by Application (2027-2032) & (US$ Million) Table 108. Asia Critical Limb Ischemia Treatment Market Size by Type (2021-2026) & (US$ Million) Table 109. Asia Critical Limb Ischemia Treatment Market Size by Type (2027-2032) & (US$ Million) Table 110. Asia Critical Limb Ischemia Treatment Market Size by Application (2021-2026) & (US$ Million) Table 111. Asia Critical Limb Ischemia Treatment Market Size by Application (2027-2032) & (US$ Million) Table 112. Asia Critical Limb Ischemia Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 113. Asia Critical Limb Ischemia Treatment Market Size by Country (2021-2026) Table 114. Asia Critical Limb Ischemia Treatment Market Size by Country (2027-2032) Table 115. South America, Middle East & Africa Critical Limb Ischemia Treatment Market Size by Type (2021-2026) & (US$ Million) Table 116. South America, Middle East & Africa Critical Limb Ischemia Treatment Market Size by Type (2027-2032) & (US$ Million) Table 117. South America, Middle East & Africa Critical Limb Ischemia Treatment Market Size by Application (2021-2026) & (US$ Million) Table 118. South America, Middle East & Africa Critical Limb Ischemia Treatment Market Size by Application (2027-2032) & (US$ Million) Table 119. South America, Middle East & Africa Critical Limb Ischemia Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 120. South America, Middle East & Africa Critical Limb Ischemia Treatment Market Size by Country (2021-2026) Table 121. South America, Middle East & Africa Critical Limb Ischemia Treatment Market Size by Country (2027-2032) Table 122. Research Programs/Design for This Report Table 123. Authors List of This Report Table 124. Secondary Sources Table 125. Primary Sources List of Figures Figure 1. Critical Limb Ischemia Treatment Product Image Figure 2. Global Critical Limb Ischemia Treatment Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Critical Limb Ischemia Treatment Market Share by Type: 2025 VS 2032 Figure 4. Embolic Protection Devices Image Figure 5. Peripheral Dilatation Systems Image Figure 6. Drugs Treatment Image Figure 7. Other Image Figure 8. Global Critical Limb Ischemia Treatment Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Critical Limb Ischemia Treatment Market Share by Application: 2025 VS 2032 Figure 10. ASCs Image Figure 11. Hospitals Image Figure 12. Catheterization Laboratory Image Figure 13. Global Critical Limb Ischemia Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Critical Limb Ischemia Treatment Market Size (2021-2032) & (US$ Million) Figure 15. Global Critical Limb Ischemia Treatment Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global Critical Limb Ischemia Treatment Market Share by Players in 2025 Figure 18. Global Top 5 and 10 Critical Limb Ischemia Treatment Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Critical Limb Ischemia Treatment Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Critical Limb Ischemia Treatment Revenue Market Share by Type (2021-2032) Figure 22. Global Critical Limb Ischemia Treatment Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Critical Limb Ischemia Treatment Revenue Market Share by Application (2021-2032) Figure 24. North America Critical Limb Ischemia Treatment Market Size (2021-2032) & (US$ Million) Figure 25. North America Critical Limb Ischemia Treatment Market Share by Type (2021-2032) Figure 26. North America Critical Limb Ischemia Treatment Market Share by Application (2021-2032) Figure 27. North America Critical Limb Ischemia Treatment Market Share by Country (2021-2032) Figure 28. United States Critical Limb Ischemia Treatment Market Size (2021-2032) & (US$ Million) Figure 29. Canada Critical Limb Ischemia Treatment Market Size (2021-2032) & (US$ Million) Figure 30. Mexico Critical Limb Ischemia Treatment Market Size (2021-2032) & (US$ Million) Figure 31. Europe Critical Limb Ischemia Treatment Market Size (2021-2032) & (US$ Million) Figure 32. Europe Critical Limb Ischemia Treatment Market Share by Type (2021-2032) Figure 33. Europe Critical Limb Ischemia Treatment Market Share by Application (2021-2032) Figure 34. Europe Critical Limb Ischemia Treatment Market Share by Country (2021-2032) Figure 35. Germany Critical Limb Ischemia Treatment Market Size (2021-2032) & (US$ Million) Figure 36. France Critical Limb Ischemia Treatment Market Size (2021-2032) & (US$ Million) Figure 37. U.K. Critical Limb Ischemia Treatment Market Size (2021-2032) & (US$ Million) Figure 38. Italy Critical Limb Ischemia Treatment Market Size (2021-2032) & (US$ Million) Figure 39. Russia Critical Limb Ischemia Treatment Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries Critical Limb Ischemia Treatment Market Size (2021-2032) & (US$ Million) Figure 41. China Critical Limb Ischemia Treatment Market Size (2021-2032) & (US$ Million) Figure 42. China Critical Limb Ischemia Treatment Market Share by Type (2021-2032) Figure 43. China Critical Limb Ischemia Treatment Market Share by Application (2021-2032) Figure 44. Asia Critical Limb Ischemia Treatment Market Size (2021-2032) & (US$ Million) Figure 45. Asia Critical Limb Ischemia Treatment Market Share by Type (2021-2032) Figure 46. Asia Critical Limb Ischemia Treatment Market Share by Application (2021-2032) Figure 47. Asia Critical Limb Ischemia Treatment Market Share by Country (2021-2032) Figure 48. Japan Critical Limb Ischemia Treatment Market Size (2021-2032) & (US$ Million) Figure 49. South Korea Critical Limb Ischemia Treatment Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan Critical Limb Ischemia Treatment Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia Critical Limb Ischemia Treatment Market Size (2021-2032) & (US$ Million) Figure 52. India Critical Limb Ischemia Treatment Market Size (2021-2032) & (US$ Million) Figure 53. Australia Critical Limb Ischemia Treatment Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Critical Limb Ischemia Treatment Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Critical Limb Ischemia Treatment Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa Critical Limb Ischemia Treatment Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa Critical Limb Ischemia Treatment Market Share by Country (2021-2032) Figure 58. Brazil Critical Limb Ischemia Treatment Market Size (2021-2032) & (US$ Million) Figure 59. South Africa Critical Limb Ischemia Treatment Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Critical Limb Ischemia Treatment Market Size (2021-2032) & (US$ Million) Figure 61. Turkey Critical Limb Ischemia Treatment Market Size (2021-2032) & (US$ Million) Figure 62. Argentina Critical Limb Ischemia Treatment Market Size (2021-2032) & (US$ Million) Figure 63. UAE Critical Limb Ischemia Treatment Market Size (2021-2032) & (US$ Million) Figure 64. Egypt Critical Limb Ischemia Treatment Market Size (2021-2032) & (US$ Million) Figure 65. Chile Critical Limb Ischemia Treatment Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Embolic Protection Devices
  • Peripheral Dilatation Systems
  • Drugs Treatment
  • Other
Applications
  • ASCs
  • Hospitals
  • Catheterization Laboratory
Companies covered
  • Medtronic
  • Boston Scientific
  • Abbott
  • COOK
  • Cardiovascular Systems
  • Terumo
  • B. Braun
  • Biotronik
  • MicroPort Medical
  • Lepu Medical
  • Micro Medical Solutions

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Critical Limb Ischemia Treatment Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Embolic Protection Devices
  5. 1.2.3 Peripheral Dilatation Systems
  6. 1.2.4 Drugs Treatment
  7. 1.2.5 Other
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Critical Limb Ischemia Treatment Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 ASCs
  11. 1.3.3 Hospitals
  12. 1.3.4 Catheterization Laboratory
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global Critical Limb Ischemia Treatment Growth Trends by Region
  15. 1.5.1 Global Critical Limb Ischemia Treatment Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 Critical Limb Ischemia Treatment Market Size by Region (2021-2026)
  17. 1.5.3 Critical Limb Ischemia Treatment Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global Critical Limb Ischemia Treatment Market Dynamics
  1. 2.1 Critical Limb Ischemia Treatment Industry Trends
  2. 2.2 Critical Limb Ischemia Treatment Industry Drivers
  3. 2.3 Critical Limb Ischemia Treatment Industry Opportunities and Challenges
  4. 2.4 Critical Limb Ischemia Treatment Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Critical Limb Ischemia Treatment Revenue by Company (2021-2026)
  2. 3.2 Global Critical Limb Ischemia Treatment Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Critical Limb Ischemia Treatment Key Company Head office and Area Served
  4. 3.4 Global Critical Limb Ischemia Treatment Company, Product Type & Application
  5. 3.5 Global Critical Limb Ischemia Treatment Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Critical Limb Ischemia Treatment Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Critical Limb Ischemia Treatment Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Critical Limb Ischemia Treatment Tier 1, Tier 2, and Tier 3
4 Critical Limb Ischemia Treatment Market by Type
  1. 4.1 Global Critical Limb Ischemia Treatment Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Critical Limb Ischemia Treatment Market Size by Type (2021-2032)
  3. 4.3 Global Critical Limb Ischemia Treatment Market Size Share by Type (2021-2032)
5 Critical Limb Ischemia Treatment Market by Application
  1. 5.1 Global Critical Limb Ischemia Treatment Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Critical Limb Ischemia Treatment Market Size by Application (2021-2032)
  3. 5.3 Global Critical Limb Ischemia Treatment Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Medtronic
  2. 6.1.1 Medtronic Company Information
  3. 6.1.2 Medtronic Business Overview
  4. 6.1.3 Medtronic Critical Limb Ischemia Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Medtronic Critical Limb Ischemia Treatment Product Portfolio
  6. 6.1.5 Medtronic Recent Developments
  7. 6.2 Boston Scientific
  8. 6.2.1 Boston Scientific Company Information
  9. 6.2.2 Boston Scientific Business Overview
  10. 6.2.3 Boston Scientific Critical Limb Ischemia Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Boston Scientific Critical Limb Ischemia Treatment Product Portfolio
  12. 6.2.5 Boston Scientific Recent Developments
  13. 6.3 Abbott
  14. 6.3.1 Abbott Company Information
  15. 6.3.2 Abbott Business Overview
  16. 6.3.3 Abbott Critical Limb Ischemia Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Abbott Critical Limb Ischemia Treatment Product Portfolio
  18. 6.3.5 Abbott Recent Developments
  19. 6.4 COOK
  20. 6.4.1 COOK Company Information
  21. 6.4.2 COOK Business Overview
  22. 6.4.3 COOK Critical Limb Ischemia Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 COOK Critical Limb Ischemia Treatment Product Portfolio
  24. 6.4.5 COOK Recent Developments
  25. 6.5 Cardiovascular Systems
  26. 6.5.1 Cardiovascular Systems Company Information
  27. 6.5.2 Cardiovascular Systems Business Overview
  28. 6.5.3 Cardiovascular Systems Critical Limb Ischemia Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Cardiovascular Systems Critical Limb Ischemia Treatment Product Portfolio
  30. 6.5.5 Cardiovascular Systems Recent Developments
  31. 6.6 Terumo
  32. 6.6.1 Terumo Company Information
  33. 6.6.2 Terumo Business Overview
  34. 6.6.3 Terumo Critical Limb Ischemia Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Terumo Critical Limb Ischemia Treatment Product Portfolio
  36. 6.6.5 Terumo Recent Developments
  37. 6.7 B. Braun
  38. 6.7.1 B. Braun Company Information
  39. 6.7.2 B. Braun Business Overview
  40. 6.7.3 B. Braun Critical Limb Ischemia Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 B. Braun Critical Limb Ischemia Treatment Product Portfolio
  42. 6.7.5 B. Braun Recent Developments
  43. 6.8 Biotronik
  44. 6.8.1 Biotronik Company Information
  45. 6.8.2 Biotronik Business Overview
  46. 6.8.3 Biotronik Critical Limb Ischemia Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Biotronik Critical Limb Ischemia Treatment Product Portfolio
  48. 6.8.5 Biotronik Recent Developments
  49. 6.9 MicroPort Medical
  50. 6.9.1 MicroPort Medical Company Information
  51. 6.9.2 MicroPort Medical Business Overview
  52. 6.9.3 MicroPort Medical Critical Limb Ischemia Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 MicroPort Medical Critical Limb Ischemia Treatment Product Portfolio
  54. 6.9.5 MicroPort Medical Recent Developments
  55. 6.10 Lepu Medical
  56. 6.10.1 Lepu Medical Company Information
  57. 6.10.2 Lepu Medical Business Overview
  58. 6.10.3 Lepu Medical Critical Limb Ischemia Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Lepu Medical Critical Limb Ischemia Treatment Product Portfolio
  60. 6.10.5 Lepu Medical Recent Developments
  61. 6.11 Micro Medical Solutions
  62. 6.11.1 Micro Medical Solutions Company Information
  63. 6.11.2 Micro Medical Solutions Business Overview
  64. 6.11.3 Micro Medical Solutions Critical Limb Ischemia Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Micro Medical Solutions Critical Limb Ischemia Treatment Product Portfolio
  66. 6.11.5 Micro Medical Solutions Recent Developments
7 North America
  1. 7.1 North America Critical Limb Ischemia Treatment Market Size (2021-2032)
  2. 7.2 North America Critical Limb Ischemia Treatment Market Size by Type
  3. 7.2.1 North America Critical Limb Ischemia Treatment Market Size by Type (2021-2026)
  4. 7.2.2 North America Critical Limb Ischemia Treatment Market Size by Type (2027-2032)
  5. 7.2.3 North America Critical Limb Ischemia Treatment Market Share by Type (2021-2032)
  6. 7.3 North America Critical Limb Ischemia Treatment Market Size by Application
  7. 7.3.1 North America Critical Limb Ischemia Treatment Market Size by Application (2021-2026)
  8. 7.3.2 North America Critical Limb Ischemia Treatment Market Size by Application (2027-2032)
  9. 7.3.3 North America Critical Limb Ischemia Treatment Market Share by Application (2021-2032)
  10. 7.4 North America Critical Limb Ischemia Treatment Market Size by Country
  11. 7.4.1 North America Critical Limb Ischemia Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Critical Limb Ischemia Treatment Market Size by Country (2021-2026)
  13. 7.4.3 North America Critical Limb Ischemia Treatment Market Size by Country (2027-2032)
  14. 7.4.4 North America Critical Limb Ischemia Treatment Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Critical Limb Ischemia Treatment Market Size (2021-2032)
  2. 8.2 Europe Critical Limb Ischemia Treatment Market Size by Type
  3. 8.2.1 Europe Critical Limb Ischemia Treatment Market Size by Type (2021-2026)
  4. 8.2.2 Europe Critical Limb Ischemia Treatment Market Size by Type (2027-2032)
  5. 8.2.3 Europe Critical Limb Ischemia Treatment Market Share by Type (2021-2032)
  6. 8.3 Europe Critical Limb Ischemia Treatment Market Size by Application
  7. 8.3.1 Europe Critical Limb Ischemia Treatment Market Size by Application (2021-2026)
  8. 8.3.2 Europe Critical Limb Ischemia Treatment Market Size by Application (2027-2032)
  9. 8.3.3 Europe Critical Limb Ischemia Treatment Market Share by Application (2021-2032)
  10. 8.4 Europe Critical Limb Ischemia Treatment Market Size by Country
  11. 8.4.1 Europe Critical Limb Ischemia Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Critical Limb Ischemia Treatment Market Size by Country (2021-2026)
  13. 8.4.3 Europe Critical Limb Ischemia Treatment Market Size by Country (2027-2032)
  14. 8.4.4 Europe Critical Limb Ischemia Treatment Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Critical Limb Ischemia Treatment Market Size (2021-2032)
  2. 9.2 China Critical Limb Ischemia Treatment Market Size by Type
  3. 9.2.1 China Critical Limb Ischemia Treatment Market Size by Type (2021-2026)
  4. 9.2.2 China Critical Limb Ischemia Treatment Market Size by Type (2027-2032)
  5. 9.2.3 China Critical Limb Ischemia Treatment Market Share by Type (2021-2032)
  6. 9.3 China Critical Limb Ischemia Treatment Market Size by Application
  7. 9.3.1 China Critical Limb Ischemia Treatment Market Size by Application (2021-2026)
  8. 9.3.2 China Critical Limb Ischemia Treatment Market Size by Application (2027-2032)
  9. 9.3.3 China Critical Limb Ischemia Treatment Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Critical Limb Ischemia Treatment Market Size (2021-2032)
  2. 10.2 Asia Critical Limb Ischemia Treatment Market Size by Type
  3. 10.2.1 Asia Critical Limb Ischemia Treatment Market Size by Type (2021-2026)
  4. 10.2.2 Asia Critical Limb Ischemia Treatment Market Size by Type (2027-2032)
  5. 10.2.3 Asia Critical Limb Ischemia Treatment Market Share by Type (2021-2032)
  6. 10.3 Asia Critical Limb Ischemia Treatment Market Size by Application
  7. 10.3.1 Asia Critical Limb Ischemia Treatment Market Size by Application (2021-2026)
  8. 10.3.2 Asia Critical Limb Ischemia Treatment Market Size by Application (2027-2032)
  9. 10.3.3 Asia Critical Limb Ischemia Treatment Market Share by Application (2021-2032)
  10. 10.4 Asia Critical Limb Ischemia Treatment Market Size by Country
  11. 10.4.1 Asia Critical Limb Ischemia Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Critical Limb Ischemia Treatment Market Size by Country (2021-2026)
  13. 10.4.3 Asia Critical Limb Ischemia Treatment Market Size by Country (2027-2032)
  14. 10.4.4 Asia Critical Limb Ischemia Treatment Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Critical Limb Ischemia Treatment Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Critical Limb Ischemia Treatment Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Critical Limb Ischemia Treatment Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Critical Limb Ischemia Treatment Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Critical Limb Ischemia Treatment Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Critical Limb Ischemia Treatment Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Critical Limb Ischemia Treatment Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Critical Limb Ischemia Treatment Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Critical Limb Ischemia Treatment Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Critical Limb Ischemia Treatment Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Critical Limb Ischemia Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Critical Limb Ischemia Treatment Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Critical Limb Ischemia Treatment Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Critical Limb Ischemia Treatment Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst